CompoAtlas

Alcoolature de Fenouil fruit

Food supplement declared in France, decision dated 21 November 2024

Alcoolature de Fenouil fruit (l'herbe vive) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
l'herbe vive
Food business operator placing the product on the market
Elodie BUTIN
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Compte-gouttes
Daily dose
120 gouttes
Directions for use
40 gouttes 2 à 3 fois par jour dans un peu d’eau, hors des repas. Agiter avant emploi.
Intended populations
Population générale
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous anticoagulants, Sous antidiabétiques, Ulcère (estomac ou duodenum)
Objectives stated by the manufacturer (these are not authorised claims)
Cycles féminins, Digestion

Declaration 2796, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Foeniculum vulgare Mill.FruitAlcoolature540 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

déconseillé avant 12 ans, pendant la grossesse et l’allaitement, allergie croisée connue aux Apiacées (anis, céleri, etc.), au pollen d’armoise ou à l’anéthole. Prendre conseil auprès d’un professionnel de santé en cas de prise concomitante de médicament, de traitement antidiabétique, anticoagulant, d’ulcère gastrique ou d’hémophilie. Associer à une alimentation équilibrée et un mode de vie sain. Ne pas dépasser la dose recomandée. Tenir hors de portée des enfants.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Foeniculum vulgare Mill.
    Read the warning, when it applies and the studies cited

    BITTER FENNEL- FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Essential oil and Tincture.

    Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

    SWEET FENNEL -FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : l'herbe vive

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line